147

therapeutic
published patents

56

oncology
published patents

310

research tools

46

diagnostic
published patents

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

Applications
Therapy areas
Download
NORMAL SEARCH
ADVANCED SEARCH
More posts
BIO22443-D1

Methods of diagnosing acute circulatory failure

Circulatory failure generates hypoxia and leads to accumulation of reductive species in tissue and circulatory failure monitoring tools are needed but […]

Read more

You might also be interested in

BIO23267-T1

New compounds and use thereof

The present invention relates to the treatment of cancer. Here, the inventors evaluated EAPB02303 […]

Read more
BIO25003-T1

Methods for treating solid cancers combining low

Immunotherapy has transformed cancer treatment but often struggles with solid tumors due to immune […]

Read more
BIO22091-T1

New method to treat brain or neurologic disorders

The present invention relates to the treatment of brain or neurologic disorders. In this study, the […]

Read more
BIO23082-T1

Methods of prognosis and treatment of patients

Melanoma cell plasticity plays a key role in the acquisition of resistance to therapy. […]

Read more
BIO22435-T1

Methods for the treatment of b-cell lymphoma

The Inventors herein demonstrate that CD39 is a relevant therapeutic target in B-cell
lymphoma, […]

Read more
BIO23360-D1

Method to predict the risk of a cardiovascular

The present invention relates to cardiovascular event in a patient with type 2 diabetes. In a […]

Read more
BIO20383-D1

Method for quantifying ahsp protein and its use

The Alpha haemoglobin-stabilising protein (AHSP) is a key chaperone molecule synthesised in red […]

Read more
BIO23521-T1

Methods of treating cancer combining uros

Thanks to its very high genome-editing efficiency, CRISPR-Cas9 technology could be a promising […]

Read more
BIO24140-D1

Method for determining the age of red blood cells

Glycated Hb was measured in reticulocytes (RNA-positive cells) and was correlated to a decrease in […]

Read more
BIO23407-D1

Absolute quantification of human serum albumin

The inventors developed a novel and reliable top-down RPLC-MS method for the absolute quantification […]

Read more
BIO21430-D1

Methods for the diagnosis, prognosis and the

Allogeneic kidney transplantation is a common transplant procedure and an optimal
form of […]

Read more
BIO24521-D1

Use of soluble cd95l as a prognostic marker in

PTLDs arise after solid organ and hematopoietic stem cell transplants, with occurrences linked to […]

Read more